Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD

Chest

Volumn 127, Issue 6, 2005, Pages 1911-1918

  Tsoumakidou, Maria ^a   Tzanakis, Nikolaos ^a   Chrysofakis, Georgios ^a   Siafakas, Nikolaos M ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Chronic bronchitis; Emphysema; Exacerbation; Heme oxygenase; Inducible nitric oxide synthase; Inflammation; Nitrotyrosine; Oxidative stress; Sputum

Indexed keywords

3 NITROTYROSINE; EOSINOPHIL CATIONIC PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; MYELOPEROXIDASE; BIOLOGICAL MARKER; HEME OXYGENASE; HMOX1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NITRIC OXIDE SYNTHASE; PEROXIDASE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MACROPHAGE; MALE; NITROSATIVE STRESS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; SPUTUM ANALYSIS; BRONCHITIS; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; ENZYMOLOGY; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPUTUM;

AGED; BIOLOGICAL MARKERS; BRONCHITIS; COHORT STUDIES; DISEASE PROGRESSION; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PEROXIDASE; PROBABILITY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPUTUM; STATISTICS, NONPARAMETRIC;

EID: 21844476459     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.6.1911     Document Type: Article

References (41)

1. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): the European Respiratory Society Task Force. Eur Respir J 1995; 8:1398-1420
2. Siafakas NM, Anthonisen NR, Georgopoulos D. Acute exacerbations of chronic obstructive pulmonary disease: lung biology in health and disease. New York, NY: Marcel Dekker, 2003; 183
3. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
4. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1418-1422
5. Wedzicha JA. Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002; 121(suppl):136S-141S
6. Morse D, Choi AM. Heme oxygenase-1: the "emerging molecule" has arrived. Am J Respir Cell Mol Biol 2002; 27:8-16
7. Kroncke KD, Fehsel K, Suschek C, et al. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol 2001; 1:1407-1420
8. Murata M, Kawanishi S. Oxidative DNA damage induced by nitrotyrosine, a biomarker of inflammation. Biochem Biophys Res Commun 2004; 316:123-128
9. Davis IC, Zhu S, Sampson JB, et al. Inhibition of human surfactant protein A function by oxidation intermediates of nitrite. Free Radic Biol Med 2002; 33:1703-1713
10. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-29
11. Tsoumakidou M, Tzanakis N, Siafakas NM. Induced sputum in the investigation of airway inflammation of COPD. Respir Med 2003; 97:863-871
12. Woolhouse IS, Bayle DL, Stockley RA. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002; 57:667-671
13. Keatings VM, Collins PD, Scott DM, et al. Differences in inteleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534
14. Louis R, Shute J, Biagi S, et al. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum. Am J Respir Crit Care Med 1997; 155:466-472
15. Koller DY, Nething I, Otto J, et al. Cytokine concentration in sputum from patients with cystic fibrosis and their relation to eosinophil activity. Am J Respir Crit Care Med 1997; 155: 1050-1054
16. Gibson PG, Wooley KL, Carty K, et al. Induced sputum eosinophil cationic protein(ECP) measurement in asthma and chronic obstructive airway disease (COAD). Clin Exp Allergy 1998; 28:1081-1088
17. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55:114-120
18. Gompertz S, Bayley DL, Hill SL, et al. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax 2001; 56:36-41
19. Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy 1996; 26:766-774
20. Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150:1646-1652
21. Zhu J, Qiu YS, Majumdar S, et al. Exacerbations of bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med 2001; 164:109-116
22. Qiu Y, Zhu J, Bandi V, et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168:968-975
23. Crooks SW, Bayley DL, Hill SL, et al. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J 2000; 15:274-280
24. Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:349-355
25. Gompertz S, O'Brien C, Bayley DL, et al. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001; 17:1112-1119
26. Beeh KM, Kornmann O, Buhl R, et al. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 2003; 123:1240-1247
27. Woolhouse IS, Bayley DL, Stockley RA. Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of α(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8. Thorax 2002; 57:709-714
28. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003; 58:294-298
29. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-κ. Int J Mol Med 1999; 4:223-230
30. Venge P, Bystrom J, Carlson M, et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999; 29:1172-1186
31. Park CS, Choi YS, Ki SY, et al. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. Eur Respir J 1998; 12:872-878
32. Ichinose M, Sugiura H, Yamagata S, et al. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000; 162:701-706
33. Maestrelli P, Paska C, Saetta M, et al. Decreased heme oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J 2003; 21:971-976
34. Agusti AG, Villaverde JM, Togores B, et al. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1999; 14:523-528
35. Dekhuijzen PN, Aben KK, Dekker I, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:813-816
36. Rahman I, Morrison D, Donaldson K, et al. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154:1055-1060
37. Rahman I, Skwarska E, MacNee W. Attenuation of oxidant/ antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 1997; 52:565-568
38. Guo FH, Comhair SA, Zheng S, et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol 2000; 164:5970-5980
39. Kharitonov SA, Barnes PJ. Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease. Curr Allergy Asthma Rep 2003; 3:121-129
40. Maestrelli P, El Messlemani AH, De Fina O, et al. Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers. Am J Respir Crit Care Med 2001; 164:1508-1513
41. Otterbein LE, Kolls JK, Mantell LL, et al. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 1999; 103:1047-1054